ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients

1Karch SB, editor. Drug Abuse Handbook. 2^nd ed. Boca Raton: CRC Press; 2006. Karch SB editor Drug Abuse Handbook 2^nd ed Boca Raton CRC Press 200610.1201/9781420003468Search in Google Scholar

2Foster DJ, Somogyi AA, Bochner F. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4. Br J Clin Pharmacol 1999; 47 : 403 – 12. doi: 10.1046/j.1365-2125.1999.00921.x Foster DJ Somogyi AA Bochner F. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4 Br J Clin Pharmacol 1999 47 403 12 doi 10.1046/j.1365-2125.1999.00921.x201423110233205Open DOISearch in Google Scholar

3Totah RA, Allen KE, Sheffels P, Whittington D, Kharasch ED. Enantiomeric metabolic interactions and stereoselective human methadone metabolism. J Pharmacol Exp Ther 2007;321:389–99. doi: 10.1124/jpet.106.117580 Totah RA Allen KE Sheffels P Whittington D Kharasch ED Enantiomeric metabolic interactions and stereoselective human methadone metabolism J Pharmacol Exp Ther 2007321389 99 doi 10.1124/jpet.106.11758017259447Open DOISearch in Google Scholar

4Yongfang Li, Kantelip JP, Gerritsen-van Schieveen P, Davani S. Interindividual variability of methadone response: impact of genetic polymorphism. Mol Diagn Ther 2008;12:109–24. doi: 10.1007/BF03256276 Yongfang Li Kantelip JP Gerritsen-van Schieveen P Davani S Interindividual variability of methadone response: impact of genetic polymorphism Mol Diagn Ther 200812109 24 doi 10.1007/BF0325627618422375Open DOISearch in Google Scholar

5Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid- dependent individuals. Clin Pharmacol Ther 2006;80:682–90. doi: 10.1016/j. clpt.2006.09.011 Coller JK Barratt DT Dahlen K Loennechen MH Somogyi AA. ABCB1 genetic variability and methadone dosage requirements in opioid- dependent individuals Clin Pharmacol Ther 200680682 90 doi 10.1016/j.clpt.2006.09.01117178268Open DOISearch in Google Scholar

6Richards-Waugh LL, Primerano DA, Dementieva Y, Kraner JC, Rankin GO. Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism. J Anal Toxicol 2014;38:541–7. doi: 10.1093/jat/bku091 Richards-Waugh LL Primerano DA Dementieva Y Kraner JC Rankin GO Fatal methadone toxicity: potential role of CYP3A4 genetic polymorphism J Anal Toxicol 201438541 7 doi 10.1093/jat/bku091422988825217544Open DOISearch in Google Scholar

7Sutlovic D, Kljucevic Z, Sliskovic L, Susnjar H, Viskovic I, Definis-Gojanovic M. Methadone maintenance treatment: a 15-year retrospective study in Split-Dalmatia County, Croatia. Ther Drug Monit 2018;40:486–94. doi: 10.1097/FTD.0000000000000519 Sutlovic D Kljucevic Z Sliskovic L Susnjar H Viskovic I Definis-Gojanovic M Methadone maintenance treatment: a 15-year retrospective study in Split-Dalmatia County, Croatia Ther Drug Monit 201840486 94 doi 10.1097/FTD.000000000000051929649094Open DOISearch in Google Scholar

8Ključević Z, Benzon B, Ključević N, Veršić Bratinčević M, Sutlović D. Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study. Croat Med J 2018;59:298–306. doi: 10.3325/cmj.2018.59.298 Ključević Z Benzon B Ključević N Veršić Bratinčević M Sutlović D Liver damage indices as a tool for modifying methadone maintenance treatment: a cross-sectional study Croat Med J 201859298 306 doi 10.3325/cmj.2018.59.298Open DOISearch in Google Scholar

9Bogdanović Z, Marinović-Terzić I, Kuret S, Jerončić A, Bradarić N, Forempoher G, Polašek O, Anđelinović Š, Terzić J. The impact of IL-6 and IL-28B genepolymorphisms on treatment outcome ofchronic hepatitis C infection amongintravenous drug users in Croatia. PeerJ 2016;4:e2576. doi: 10.7717/peerj.2576 Bogdanović Z Marinović-Terzić I Kuret S Jerončić A Bradarić N Forempoher G Polašek O Anđelinović Š Terzić J The impact of IL-6 and IL-28B genepolymorphisms on treatment outcome ofchronic hepatitis C infection amongintravenous drug users in Croatia PeerJ 20164e2576 doi 10.7717/peerj.2576508858227812403Open DOISearch in Google Scholar

10Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317–25. doi: 10.1002/hep.21178 Sterling RK Lissen E Clumeck N Sola R Correa MC Montaner J Sulkowski MS Torriani FJ Dieterich DT Thomas DL Messinger D Nelson M Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection Hepatology 2006431317 25 doi 10.1002/hep.2117816729309Open DOISearch in Google Scholar

11Veršić Bratinčević M, Visković T, Sutlović D. Comparison of the solid phase and liquid-liquid extraction methods for methadone determination in human serum and whole blood samples using gas chromatography/mass spectrometry. Arh Hig Rada Toksikol 2017;68:308–14. doi: 10.1515/aiht-2017-68-2953 Veršić Bratinčević M Visković T Sutlović D Comparison of the solid phase and liquid-liquid extraction methods for methadone determination in human serum and whole blood samples using gas chromatography/mass spectrometry Arh Hig Rada Toksikol 201768308 14 doi 10.1515/aiht-2017-68-295329337687Open DOISearch in Google Scholar

12Laboratory of Immunogenomics and Immunoproteomics. Files [displayed 26 August 2020]. Available at http://www.dr-petrek.eu/documents/HWE.xls Laboratory of Immunogenomics and Immunoproteomics. Files [displayed 26 August 2020] Available at http://www.dr-petrek.eu/documents/HWE.xlsSearch in Google Scholar

13Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 2008;108:363–74. doi: 10.1097/ALN.0b013e3181642938 Totah RA Sheffels P Roberts T Whittington D Thummel K Kharasch ED Role of CYP2B6 in stereoselective human methadone metabolism Anesthesiology 2008108363 74 doi 10.1097/ALN.0b013e318164293818292673Open DOISearch in Google Scholar

14Ahmad T, Sabet S, Primerano DA, Richards-Waugh LL, Rankin G. Tell-tale SNPs: The role of CYP2B6 in methadone fatalities. J Anal Toxicol 2017;41:325–33. doi: 10.1093/jat/bkw135 Ahmad T Sabet S Primerano DA Richards-Waugh LL Rankin G Tell-tale SNPs: The role of CYP2B6 in methadone fatalities J Anal Toxicol 201741325 33 doi 10.1093/jat/bkw135541202528184434Open DOISearch in Google Scholar

15Dennis BB, Bawor M, Thabane L, Sohani Z, Samaan Z. Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis. PLoS One 2014;9(1):e86114. doi: 10.1371/journal.pone.0086114 Dennis BB Bawor M Thabane L Sohani Z Samaan Z Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: A systematic review and meta-analysis PLoS One 201491e86114 doi 10.1371/journal.pone.0086114390602824489693Open DOISearch in Google Scholar

16Wu SL, Wang SC, Tsou HH, Kuo HW, Ho IK, Liu SW, Hsu Y-T, Chang Y-S, Liu Y-L. Hepatitis C virus infection influences the S-methadone metabolite plasma concentration. PloS One 2013;8(7):e69310. doi: 10.1371/journal. pone.0069310 Wu SL Wang SC Tsou HH Kuo HW Ho IK Liu SW Hsu Y-T Chang Y-S Liu Y-L Hepatitis C virus infection influences the S-methadone metabolite plasma concentration PloS One 201387e69310 doi 10.1371/journal.pone.0069310372061923935979Open DOISearch in Google Scholar

17Fonseca F, de la Torre, Diaz L, Pastor A, Cuyàs E, Pizarro N, Khymenets O, Farré M, Torrens M. Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response. PloS One 2011;12:e19527. doi: 10.1371/journal. pone.0019527 Fonseca F de laTorre Diaz L Pastor A Cuyàs E Pizarro N Khymenets O Farré M Torrens M Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response PloS One 201112e19527 doi 10.1371/journal.pone.0019527309339221589866Open DOISearch in Google Scholar